Director Joshua Ruch sold 38,000 shares (38.0K) of WGS across 15 separate transactions on 2025-11-24 for $6,093,967.44, reducing holdings by 24.0%
Joshua Ruch, a Director at GeneDx Holdings, executed 15 separate sales totaling 38,000 shares (38.0K shares) for $6,093,967.44 ($6.1M) on 2025-11-24 at a blended average price of $160.37, reducing his stake from 158,083 to 120,083 shares (a 24.0% reduction of pre-transaction holdings). The stock was trading near its 52-week high at $165.61, only 1.1% below the $167.52 peak, and has appreciated significantly over the 30-day (+26.8%) and 90-day (+28.4%) periods. This large single-day sale by a director is material in absolute dollar terms ($6.1M) and represents a substantial change in the director's disclosed position. The company remains unprofitable on a full-year basis (net income $-7.6M), although recent quarterly revenue of $116.7M reflects 50.8% annual growth, highlighting a disconnect between financial performance trajectory and current valuation (P/E of 2365.86).